Literature DB >> 18440321

Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues.

Judit Marsillach1, Bharti Mackness, Michael Mackness, Francesc Riu, Raul Beltrán, Jorge Joven, Jordi Camps.   

Abstract

The paraoxonase (PON) enzyme family, comprising PON1, PON2, and PON3, are antioxidant enzymes that degrade oxidised phospholipids. We describe the immunohistochemical localisation of the PON proteins in the normal mouse. Antibodies were obtained by inoculating rabbits with peptides derived from specific sequences of mature PONs. PON1 and PON3 were detected in the skin external epithelium, acini of the sebaceous glands, tongue epithelium, acini of the submandibular gland, surface epithelia of the stomach and the intestine, hepatocytes, exocrine pancreas acini, fibre tracts of the encephalon and the spinal cord, skeletal and cardiac muscle, eye lens epithelium and retinal layers, adipocytes, chondrocytes, epithelial cells of the trachea and bronchiole, ovary follicular fluid, seminiferous tubules, spermatozoa, and kidney proximal tubules. PON2 expression was weaker than that of PON1 and PON3, and was absent in some of the tissues studied, such as submandibular gland, nerve cells, and adipocytes. In muscle cells, PON2 expression was restricted to the endomysium. Apolipoprotein A-I did not colocalise with PONs, suggesting local synthesis. This study provides an experimental model to investigate the role played by these enzymes as antioxidants and their relationship with the development of a variety of diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440321     DOI: 10.1016/j.freeradbiomed.2008.03.023

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  53 in total

1.  Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.

Authors:  Kamila Borowczyk; Diana M Shih; Hieronim Jakubowski
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation.

Authors:  Gerard Aragonès; Anabel García-Heredia; Marta Guardiola; Anna Rull; Raúl Beltrán-Debón; Judit Marsillach; Carlos Alonso-Villaverde; Bharti Mackness; Michael Mackness; Juan Pedro-Botet; Pedro Pardo-Reche; Jorge Joven; Jordi Camps
Journal:  J Lipid Res       Date:  2011-10-14       Impact factor: 5.922

3.  Paraoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis.

Authors:  Judit Marsillach; Jessica O Becker; Tomas Vaisar; Bevra H Hahn; John D Brunzell; Clement E Furlong; Ian H de Boer; Maureen A McMahon; Andrew N Hoofnagle
Journal:  J Proteome Res       Date:  2015-03-13       Impact factor: 4.466

Review 4.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 5.  Human PON1, a biomarker of risk of disease and exposure.

Authors:  C E Furlong; S M Suzuki; R C Stevens; J Marsillach; R J Richter; G P Jarvik; H Checkoway; A Samii; L G Costa; A Griffith; J W Roberts; D Yearout; C P Zabetian
Journal:  Chem Biol Interact       Date:  2010-03-23       Impact factor: 5.192

Review 6.  Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection.

Authors:  Lucio G Costa; Rian de Laat; Khoi Dao; Claudia Pellacani; Toby B Cole; Clement E Furlong
Journal:  Neurotoxicology       Date:  2013-09-04       Impact factor: 4.294

7.  Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?

Authors:  Gennaro Giordano; Toby B Cole; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-23       Impact factor: 4.219

8.  Paraoxonase 3 functions as a chaperone to decrease functional expression of the epithelial sodium channel.

Authors:  Shujie Shi; Nicolas Montalbetti; Xueqi Wang; Brittney M Rush; Allison L Marciszyn; Catherine J Baty; Roderick J Tan; Marcelo D Carattino; Thomas R Kleyman
Journal:  J Biol Chem       Date:  2020-02-20       Impact factor: 5.157

9.  Paraoxonase 2 prevents the development of heart failure.

Authors:  Wei Li; David Kennedy; Zhili Shao; Xi Wang; Andre Klaassen Kamdar; Malory Weber; Kayla Mislick; Kathryn Kiefer; Rommel Morales; Brendan Agatisa-Boyle; Diana M Shih; Srinivasa T Reddy; Christine S Moravec; W H Wilson Tang
Journal:  Free Radic Biol Med       Date:  2018-05-02       Impact factor: 7.376

10.  Role of paraoxonase-1 in the protection of hydrogen sulfide-donating sildenafil (ACS6) against homocysteine-induced neurotoxicity.

Authors:  Xiao-Qing Tang; Rong-Qian Chen; Ling Dong; Yan-Kai Ren; Piero Del Soldato; Anna Sparatore; Duan-Fang Liao
Journal:  J Mol Neurosci       Date:  2012-07-29       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.